Select Publications
Journal articles
2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', The Lancet Regional Health - Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101119
,2024, 'Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study', PLoS ONE, 19, http://dx.doi.org/10.1371/journal.pone.0303062
,2024, 'Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26251
,2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofad637
,2024, 'Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1279572
,2023, 'Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study', The Lancet Gastroenterology and Hepatology, 8, pp. 879 - 907, http://dx.doi.org/10.1016/S2468-1253(23)00197-8
,2023, 'Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis', The Lancet Regional Health - Western Pacific, 36, http://dx.doi.org/10.1016/j.lanwpc.2023.100750
,2023, 'Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis', Vox Sanguinis, 118, pp. 471 - 479, http://dx.doi.org/10.1111/vox.13429
,2022, 'Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study', The Lancet Gastroenterology and Hepatology, 7, pp. 396 - 415, http://dx.doi.org/10.1016/S2468-1253(21)00472-6
,2022, 'Lifetime cost of HIV management in Australia: an economic model', Sexual Health, 19, http://dx.doi.org/10.1071/SH21250
,2021, 'Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications', PLoS ONE, 16, http://dx.doi.org/10.1371/journal.pone.0257369
,2021, 'Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis', PLoS ONE, 16, pp. e0245896, http://dx.doi.org/10.1371/journal.pone.0245896
,2020, 'Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model', JAMA Network Open, 3, http://dx.doi.org/10.1001/jamanetworkopen.2020.4192
,2019, 'Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016', Drug and Alcohol Dependence, 197, pp. 108 - 114, http://dx.doi.org/10.1016/j.drugalcdep.2018.11.033
,2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
,2012, 'Estimating the cost-effectiveness of needle-syringe programs in Australia.', AIDS, 26, pp. 2201 - 2210, http://dx.doi.org/10.1097/QAD.0b013e3283578b5d
,2009, 'The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 51, pp. 462 - 469, http://dx.doi.org/10.1097/QAI.0b013e3181a2539a
,2009, 'What impact might the economic crisis have on HIV epidemics in Southeast Asia?', Current HIV Research, 7, pp. 656 - 665, http://dx.doi.org/10.2174/157016209789973637
,Conference Posters
2018, 'Australia on track to achieve WHO elimination targets following rapid initial DAA treatment uptake', presented at International Liver Congress (European Association for the Study of the Liver (EASL 2018)), 11 April 2018 - 15 April 2018
,Conference Presentations
2018, 'Ongoing Burden of Advanced Liver Disease Complications Despite Rapid HCV Treatment Scale-Up', presented at Australasian Viral Hepatitis Conference, 13 August 2018 - 15 August 2018
,2017, 'Australia Could Meet the WHO HCV Elimination Targets If the Current Rollout of DAA Treatment Is Continued', presented at Australasian Viral Hepatitis Conference (AVHC), 10 August 2017 - 11 August 2017
,2009, 'Is NSP preventing HIV and HCV epidemics among Australian IDUs?: The past and future analysis', presented at The Australasian HIV/ AIDS Conference, Brisbane, Australia, 07 September 2009 - 09 September 2009
,2009, 'The impact of NSPs on HIV and HCV transmissions in IDUs in Australia: A model-based analysis', presented at International Workshop on Modelling and Data Analysis for Infectious Disease Control, Durras, NSW, Australia, 09 March 2009 - 12 March 2009
,Conference Abstracts
2021, 'LIFETIME COST OF HIV MANAGEMENT IN AUSTRALIA: A MODELLING STUDY', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. VIII - VIII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Evidence of declining HCV transmission in Australia following scale-up of direct acting antiviral therapy', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 73, pp. S606 - S606, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587002012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Reports
2023, Needle Syringe Program National Minimum Data Collection: National Data Report 2023, http://dx.doi.org/10.26190/9kav-de21, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-2023-national-data-report
,2023, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2023, Kirby Institute, UNSW Sydney, Sydney, UNSW, http://dx.doi.org/10.26190/f5ph-f972
,2022, Needle Syringe Program National Minimum Data Collection: National Data Report 2022, http://dx.doi.org/10.26190/y3nf-2x07, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-2022-national-data-report
,2022, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2022, The Kirby Institute, UNSW Sydney, Sydney, Australia, http://dx.doi.org/10.26190/sx44-5366, https://kirby.unsw.edu.au/report/asr2022
,2021, Needle Syringe Program National Minimum Data Collection: National Data Report 2021, http://dx.doi.org/10.26190/3cg0-jd64, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-2021-national-data-report
,2021, Progress towards hepatitis C elimination among Aboriginal and Torres Strait Islander people in Australia: monitoring and evaluation report, The Kirby Institute, UNSW Sydney, Sydney, Australia, https://kirby.unsw.edu.au/report/progress-towards-hepatitis-c-elimination-among-aboriginal-and-torres-strait-islander-people
,2020, Needle Syringe Program National Minimum Data Collection: National Data Report 2020, http://dx.doi.org/10.26190/a9gr-tq33, https://www.kirby.unsw.edu.au/research/reports/needle-syringe-program-national-minimum-data-collection-report-2020
,2019, Needle Syringe Program National Minimum Data Collection: National Data Report 2019, http://dx.doi.org/10.26190/cwdt-3t58, https://kirby.unsw.edu.au/report/needle-syringe-program-national-minimum-data-collection-report-2019
,2018, Needle Syringe Program National Minimum Data Collection: National Data Report 2018, http://dx.doi.org/10.26190/gsrt-6r60
,2017, Needle Syringe Program National Minimum Data Collection: National Data Report 2017, http://dx.doi.org/10.26190/5t18-bm18
,2017, 2017 Estimates and Projections of the Hepatitis C Virus Epidemic in NSW: Summary Report, Sydney: Kirby Institute, UNSW Sydney
,2017, Needle Syringe Program National Minimum Data Collection: National Data Report 2016, http://dx.doi.org/10.26190/pfsv-q451
,2011, Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam, The National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney Australia
,2010, HIV in Indonesia Model, The National HIV Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney, Australia
,2009, Evaluation of the potential impact of the global economic crisis on HIV epidemics in Southeast Asia (prepared for AusAID), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
,2009, Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs among injecting drug users in Australia, Publications Production Unit (Public Affairs, Parliamentary and Access Branch) Commonwealth Department of Health and Ageing, Canberra, Australia, 3123, http://www.nchecr.unsw.edu.au/nchecrweb.nsf/resources/Reports/$file/RO-2ReportLQ.pdf
,Preprints
2023, Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries, http://dx.doi.org/10.1101/2023.05.08.23289690
,2023, Impact of Simplified HCV Diagnostic Strategies on the HCV Epidemic Among Men Who Have Sex with Men in Taiwan: A Modelling Study, http://dx.doi.org/10.2139/ssrn.4431789
,Australia on Track to Achieve Who HCV Elimination Targets Following Rapid Initial DAA Treatment Uptake: A Modelling Study, http://dx.doi.org/10.2139/ssrn.3213670
,Lifetime Cost of HIV Management in Australia: An Economic Model, http://dx.doi.org/10.2139/ssrn.3868096
,Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267510
,Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267527
,Other
2021, The COVID-19 Incarceration Model: a tool for corrections staff to analyze outbreaks of COVID-19, http://dx.doi.org/10.1101/2021.02.18.21252032
,